The Articles of 2011*

Similar documents
Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Policy Evaluation: Step Therapy Prior Authorization of Combination Inhaled Corticosteroid / Long-Acting Beta-Agonists

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Prescription Switching and Reduced LDL-C Goal Attainment

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

HealtheCNY Indicator List by Data Source

Treating Hypertension in 2018: What Makes the Most Sense Today?

IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Ambulatory BP Monitoring: Getting the Diagnosis of Hypertension Right. Anthony J. Viera, MD, MPH, FAHA Professor and Chair

Hospital Transition Management. Barbara Wood, BSN, MBA

Dyslipidemia: Lots of Good Evidence, Less Good Interpretation.

Jan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

TACKLING COPD READMISSIONS. Wendy Presley RN

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation. Hot Off the Press and into Your Practice: The Last Year in Medical News

Update in Hypertension

Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

2/9/2017. Financial Disclosures/Unapproved Use. Achieving Harmony in Blood Pressure Guidelines Around the Globe. Roger S. Blumenthal, MD.

Update in Outpatient Medicine ACP Scientific Session November 12, 2016

Optimizing Postpartum Maternal Health to Prevent Chronic Diseases

Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

No relevant financial relationships

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

ADVANCES IN MANAGEMENT OF HYPERTENSION

Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease

Clinical and Contextual Evidence Reviews

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

The Diabetes Link to Heart Disease

No relevant financial relationships

2017 State Of The County Health Report Jones County, NC

THIS TALK STATINS REDUCE: Immortal time bias Immeasurable time bias Time-window bias TIME-RELATED BIASES IN PHARMACOEPIDEMIOLOGY

Counseling and Long-term Follow up After Gestational Disorders

Arkansas Prescription Monitoring Program

Update in Hospital Medicine. Update in Hospital Medicine 2009

Mental Health: The Role of Public Health and CDC

Blood Pressure Treatment Goals

Preventive Cardiology Scientific evidence

COPD: A Renewed Focus. Disclosures

In-Patient Sleep Testing/Management Boaz Markewitz, MD

INTERNATIONAL LIPOPROTEIN STANDARDIZATION FORUM Fasting Time and Lipid Levels in a Community-Based Population: A Crosssectional

ADVANCES IN MANAGEMENT OF HYPERTENSION

Update on Cholesterol Management: The 2013 ACC/AHA Guidelines

Development and use of the Eating, Sleeping, Consoling (ESC) Care. for opioid-exposed newborns and their families in Northern New England

Epidemiology of adolescent and young adult hospital utilization for alcohol and drug use, poisoning, and suicide attempts in the United States

Best Practices in Cardiac Care: Getting with the Guidelines

Comprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium

Med Wreck to Med Rec How medication reconciliation can (should) change your practice!

Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health

Opioid Review and MAT Clinic Comorbidities Associated with Opioid Overdose

Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA Rhode Island Cardiology Center

Hyperlipidemia in an Otherwise Healthy 80 Year-Old Patient. Theodore D Fraker, Jr, MD Professor of Medicine

Update in Hospital Medicine. Disclosures 10/30/2017. none Oregon Chapter ACP Scientific Meeting

DECLARATION OF CONFLICT OF INTEREST

Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education

Preventing and Treating High Blood Pressure

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation. Hot Off the Press and into Your Practice: The Last Year in Medical News

The Opioid Addiction Emergency In Virginia June 8, 2017

2016 Update in Geriatrics Elizabeth Eckstrom, MD, MPH Oregon Health & Science University Oregon Geriatrics Society October 7, 2016

Hypertension 2015: Recent Evidence that Will Change Your Practice

Caring for the AKI Survivor: What is Required?

The who, what, why, where, and when of Clinical Practice Guidelines (CPGs)

Is it ever too late for cardiovascular prevention and rehabilitation? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany

MEASURING CARE QUALITY

Modern Management of Hypertension: Where Do We Draw the Line?

Diabetes Mellitus: A Cardiovascular Disease

Objectives. Describe results and implications of recent landmark hypertension trials

Modern Management of Hypertension

CNODES: A Canadian Initiative

Potential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks)

Managing Hypertension in 2016

Diabetes and the Heart

Strategies for Enhancing Sepsis Survivorship

Do Elderly Men Have Increased Mortality Following Hip Fracture?

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration

LIPIDS ADVANCES IN PRIMARY CARE: STRATEGY TOPICS PRACTICE-CHANGING PAPERS FROM THE PAST YEAR. Topics:

Practical Use of Decision Aids in Primary Care. Michael Soung, MD, FACP Virginia Mason Medical Center General Internal Medicine

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

The Geriatric Trauma Institute (GTI) The Efficacy of a Dedicated Geriatric Trauma Service: A Pilot Study

MEASURING CARE QUALITY

Evolutions in Geriatric Fracture Care Preparing for the Silver Tsunami

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton

Performance Measure Name: TOB-3 Tobacco Use Treatment Provided or Offered at Discharge TOB-3a Tobacco Use Treatment at Discharge

2017 HEDIS Measures. PREVENTIVE SCREENING 2017 Measure Quality Indicator

Development and Utilization of Standardized Hip Fracture Guidelines

Update in Cardiology Pharmacologic Management of Cardiovascular Risk. Christopher C. Roe, MSN, ACNP

Huangdao People's Hospital

Transcription:

The Articles of 2011* W H A T W A S I M P O R T A N T A T L E A S T T O S O M E O F U S

Sources Essential Evidence Journal Watch Our faculty Other presentations (i.e. Frank Domino) Prioritized: key areas of FM practice might directly change clinical practice might be leading to paradigm changes

NSAIDS

Selective/Non-selective NSAIDS #1 Danish observational study 84,000 pts with 1 st MI between 1997-2006 NSAID use associated with increased risk for recurrent MI or death, hazard ratio 1.5-1.7 Some variability by NSAID Naproxen maybe better? Risks became apparent shortly after initiation of NSAID Circulation May 24; 123:2226

Selective/Non-selective NSAIDS #2 meta-analysis of evidence on cardiovascular safety of NSAIDS 31 trials, 116k patients, all kinds of NSAIDS. Conclusion: All NSAIDS seem to be associated with some CV harms BMJ 2011; 342:r7086

Selective/Non-selective NSAIDS #3 Northern Denmark Population based case-control study 32k pts with a first dx of afib/flutter, 1999-2008 People with new afib/flutter were more likely to be NSAID users, especially new users (start within 60d) Current users OR 1.17 for NSAIDS, 1.27 for Cox-2 OR for new users: 1.46 for NSAIDS, 1.71 Cox-2 Schmidt et al. BMJ 2011 Jul 4;343:d3450. doi: 10.1136/bmj.d3450.

Blood Pressure Issues

Changes to how we measure/treat hypertension? How many BP measurements should be made to diagnose hypertension? Maybe averaging 5-6 JW Gen Med Aug 1, p. 124, and Ann Intern Med Jun 21; 154:781 Accuracy of manual BP measurements? Automated BP measurements in clinic may be more accurate than manual (mitigate white coat effect? Specific devices?) JW Gen Med Mar 1, p.37, and BMJ Feb 7; 342:d286 Ambulatory BP measurement a cost-effective way to diagnose hypertension? Maybe but not covered by Medicare unless diagnosed with white coat hypertension Lancet Oct 1; 378:1219 BP goals in DM2 may not need to be <130 systolic. 130-135 systolic seems to be as good as <130 (Systematic review) Bangalore S. Circulation 2011 Jun 21; 123(24):2799-810

Outpatient Misc

Inhaled steroids, COPD and pneumonia Context: inhaled steroids increase pneumonia risk in pts with COPD. What s the significance? Retrospective cohort study, VA database Pts with COPD, hospital dc dx of pneumonia Prior use of inhaled steroids: 30-d mortality 0.80 (0.72 0.89) 90-d mortality 0.78 (0.72 0.85) Mechanical ventilation 0.83 (0.72 0.94) Vasopressors 0.88 (0.74 1.04) Chen D, Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am J Respir Crit Care Med, 2011 Aug 1:184(3):312-6

What is this intervention?

CBT for secondary prevention? 362 Swedish pts with CAD related hospitalization (75 or younger) in the previous year Intervention: traditional care vs traditional care plus CBT program focused on stress management (20 2hr sessions in a year). Outcomes: all-cause mortality, hospital admission for related conditions, AMI Results: intervention group: 41% lower rate of fatal/nonfatal recurrent CVD related events 45% fewer MIs 28% lower mortality (not quite sig) Gulliksson M Arch Intern Med. 2011;171(2):134-140. doi:10.1001/archinternmed.2010.510

AIM-HIGH NHLBI stopped clinical trial 18 months early Intervention: adding high dose, extended release niacin to statins in people with heart and vascular disease Pts with target LDL values, but low HDL and high TG Outcome: no change to CV events. HDL/TG numbers looked better, outcomes didn t NEJM Dec 15; 365:2255

Maternal/Child Health

Can you use combined OCPs with Lactating moms? RCT, 197 pts, UNM Randomized breast-feeding moms starting at 2 weeks postpartum to combined/prog only OCPs. Telephone questionnaires about continuation, pt satisfaction. Infant growth parameters measured Outcomes: Breastfeeding continuation rates at 8 weeks: 63.5% (progest only) and 64.1% (combined). No differences in contraception continuation rate No differences in measured infant growth parameters Espey, Ogburn, Leeman, et al. Obstet Gynecol. 2012 Jan;119(1):5-13.

Public Health

PSA Testing What happened? Draft Recommendation 10/31 by USPSTF- to make PSA screening D grade rec Multiple editorials, see NEJM 365 from Nov 24 Who is the USPSTF? Why now? Why does this matter/what is the controversy? Good editorial: Brett AS, et al. Prostate-Cancer Screening What the U.S. Preventive Services Task Force Left Out. NEJM 2011 365; 21: 1949-1951

Unnecessary Tests Question: what is the financial impact of the typical practices of little benefit used in primary care? Answer: a lot Data from 2 US surveys of practice, from pre-existing top 5 common but low yield practices

Copyright restrictions may apply. Kale, M. S. et al. Arch Intern Med 2011;171:1856-1858.

Is having Medicaid better than having nothing? Real question: what would happen if more people had insurance? (controversy does exist) 2008 Oregon lottery for Medicaid eligibility researchers caught wind... Followed so far only 1 year. Don t we know the answer to this? Finkelstein A et al. The Oregon health insurance experiment: Evidence from the first year. National Bureau of Economic Research 2011 Jul; [working paper] 191790:1 NY Times Article: http://www.nytimes.com/2011/07/07/health/policy/07medicaid.html

Initial (1 year) findings A long list of differences, highlighted by 25% increased utilization. Some examples: 35 % more likely to go to a clinic or see a doctor, 15 percent more likely to use prescription drugs 30 percent more likely to be admitted to a hospital (8.8% vs 6.7%). unable to detect a change in emergency room use Women with insurance: 60 percent more likely to have mammograms (49% vs 30%) more likely to have their cholesterol checked More likely to go to the same clinic/provider Reported feeling better

Increase in Fatal OD from Prescription Opiates CDC report which reviewed national databases Key points: Death from opioid pain relievers (OPR) is an epidemic Sales of OPR quadrupled between 1999 and 2010, fatal overdoses increased by about the same National death rates highest in whites 35-54 In 2008, drug OD in the United States: 36,450 deaths (37,261 deaths due to motor vehicle accidents) 20,044 prescription drug OD, 74% opiates Death rates varied by state Center for Disease Control and Prevention (CDC). Vital signs: Overdoses of prescription opioid pain relievers United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2011 Nov 4; 60:1487

In the Hospital

Are Hospitalists Cost Effective? 58k Medicare admissions reviewed 2001-2006, 456 US hospitals Mean LOS.64 days shorts, mean costs $282 lower But mean Medicare costs in 30 days after dc $332 higher for these patients. Cost shifting? Various controversies and opinions KuoY-F, Association of hospitalist care with medical utilization after discharge: Evidence of cost shift from a cohort study. Ann Int Med 2011 Aug 2; 155:152.

Unintentional Medication Discontinuation After Hospital DC Population-based cohort study, data 1997-2009 All hospitalizations, then outpatient Rx s in Ontario 396k patients aged 66 or older, who had 1 of 5 EBM indications for specific meds. Outcome: failure to renew the Rx within 90 days of hospital dc The 190k patients who were admitted were more likely to not fill meds at 90 days, especially if they went to the ICU. Bell C et al. JAMA, August 24/31, 2011-306, No. 8.

Pediatrics

Intermittent Budesonide in preschool children with recurrent wheezing 300 preschool kids with recurrent wheezing, ages 1-4. Followed for 1 year. daily low-dose nebulized budesonide (.5mg qhs neb) vs intermittent high dose budesonide (1mg) BID-7 days at onset of illness primary endpoint: exacerbations requiring oral steroids. Results: no difference NEJM Nov 24; 365:1990

Some other things

Quick tidbits About 1/3 of pts with resistant htn seem to have white coat hypertension De la Sierra A et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011 May; 57-898. Adverse Drug Events Cause Many Hospitalization in Elders. 1.5% of all hospitalizations in the elderly, and almost half of these were in pts >80. Budnitz DS et al. Emergency hospitalizations for adverse drug events in older Americans. NEJM 2011 Nov 24; 365:2002. B-Blockers in COPD Patients: lowers 4 year mortality (probably because a lot of them have CAD). No adverse effects on lung function. Use cardioselective. Short PM et al. Effect of B-Blockers in treatment of chronic obstructive pulmonary disease: A retrospective cohort stufy. BMJ 2011 May 10; 342:d2549

More tidbits PPI use associated with increased risk of SBP in cirrhotic adults (add it to the list) Trikudanathan G, Int J Clin Pract. 2011 Jun;65(6):674-8. doi: 10.1111/j.1742-1241.2011.02650 People on 3x weekly dialysis have higher mortality on the day following the 2 day dialysis hiatus. Foley RN et al. NEJM 2011 Sep 22;365(12):1099-107. Something good? U.S. HF outcomes improved 1998-2008. Hospitalization rates decreased 30%, mortality slightly decreased. Varies by state. NM has decreased hospitalization rates, but increased mortality. Chen J et al. JAMA 2011 Oct 19;306(15):1669-78.

More tidbits Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix. Hassan SS et al. Ultrasound Obstet Gynecol. 2011 Jul;38(1):18-31. doi: 10.1002/uog.9017. Epub 2011 Jun 15. Introduction of solid foods before the age of 4 months is associated with an increased risk of obesity at age 3, in formula-fed infants and infants weaned before 4 months. (OR 6.3) Huh S. Pediatrics Vol 127 No 3. March 1, 2011. Bisposphonates are associated with increased risk of atypical femur fractures. Gen Med Mar 15, p. 45

How can you stay current?